Partnering

Get involved / Investors / Collaborations / Partnering

The success of SJT Molecular project has been possible thanks to the active involvement of dozens of persons around the world who have joined our project as investors, collaborators, partners… and that are contributing to transform breakthrough novel science into new safer and more effective products that are aimed at dramatically transform medical outcomes of serious diseases affecting millions of persons worldwide.

If you want to get involved in this promising project and join us as an investor, collaborator, partner, licensee… feel free to contact us and we will be happy to evaluate a potential mutually beneficial collaboration.

We are investing in a capital increase to finance the next steps of our company, taking 3% of our shares to market.

Find out more at aec@sjtmolecular.com or +34 945 124 609

Partner with us

In order to advance our innovative R&D pipeline we are continuously seeking new collaborations through licensing, partnering, R&D alliances or other collaborations with leading players in the industry who can effectively contribute to bring novel products to the market and make them available to patients globally.

SJT Molecular is currently prioritizing partnering opportunities for its lead R&D program with SJT4A in obesity, hepatic steatosis, NASH, hypertension, dyslipidemia and type 2 diabetes, which has just in preclinical development.

We are open to discuss global partnering opportunities as well as potential collaborations with strong and motivated local development and commercial partners in specific markets like USA, Europe, Japan, Canada, Australia, Russia, South Korea, Russia or Mexico, were SJT Molecular holds strong IP rights for this product.

If you are interested in exploring partnering opportunities of our innovative R&D programs please contact us at aec@sjtmolecular.com